Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.2 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |